Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last A$91.85 AUD
Change Today +0.15 / 0.16%
Volume 2.2M
CSL On Other Exchanges
Symbol
Exchange
OTC US
Munich
OTC US
Frankfurt
As of 1:10 AM 03/27/15 All times are local (Market data is delayed by at least 15 minutes).
text size: T | T
Back to Snapshot
Company Description

Contact Info

45 Poplar Road

Parkville, VIC 3052

Australia

Phone: 61 3 9389 1911

Fax: 61 3 9389 1434

CSL Limited is a public company which is a parent company of the CSL Group. CSL business activities are carried out through its Human Health, JRH Biosciences, Animal Health and ZLB Plasma Services operations. CSL limited develops, manufactures and markets pharmaceutical products of biological origin. The company’s business is health care: Life-saving products derived from human plasma; Pharmaceuticals and diagnostics essential to health; Cell culture reagents for the pharmaceutical industry; and Veterinary vaccines and diagnostics to protect livestock and companion animals. The company’s Human Health business includes the operations of ZLB Bioplasma, CSL Bioplasma, CSL Pharmaceutical, and its global new product development activities. JRH Biosciences Pty, Ltd, based in Melbourne, is a subsidiary of CSL Limited that processes Australian animal serum used to produce cell culture media. CSL (New Zealand) Limited, based in Auckland, is a subsidiary of CSL Limited and is the New Zealand marketing arm for Australian Bioplasma, Pharmaceutical and Animal Health business operations. CSL (New Zealand) Limited also manufactures veterinary viral vaccines at a plant in Upper Hutt, near Wellington. Iscotec AB, a Swedish company, is a subsidiary of CSL Limited that has technology to enhance the immune response to vaccines. Cervax Pty, Ltd is a subsidiary of CSL Limited and is a company formed to undertake a specific research and development project. Cervax is 74% owned by CSL. CSL International Pty, Ltd is a subsidiary of CSL Limited and the holding company for the international operations of the CSL Group. CSL Denmark ApS is a subsidiary of CSL International Pty Ltd and the holding company for the European subsidiaries of the Group. CSL US, Inc. is a subsidiary of CSL International Pty Ltd and the holding company for the US operations of the CSL Group. CSL Finance Pty, Ltd is a subsidiary of CSL International Pty Ltd through which the CSL Group raises debt funding. JRH Biosciences, Inc. is a subsidiary of CSL US, Inc. Based in Kansas in the US, it is one of the manufacturers of specialised cell culture media in the world. JRH Biosciences, Inc. has manufacturing sites in Kansas and Pennsylvania. Biocor Animal Health Inc. is a subsidiary of CSL US, Inc. Based in the US at Omaha in Nebraska, Biocor manufactures and markets veterinary vaccines and is operationally part of CSL's Animal Health Group. ZLB Bioplasma, Inc., a Los Angeles based subsidiary of CSL US, Inc., is operationally part of ZLB Bioplasma AG. In the US, ZLB Bioplasma, Inc. markets and distributes plasma-derived products and operates ZLB Plasma Services, a Florida based plasma collection business. ZLB Bioplasma AG., based in Bern, Switzerland, is a subsidiary of CSL Denmark ApS. ZLB Bioplasma AG manufactures plasmaderived products and has major markets in the US and Europe. ZLB Bioplasma Belgium sprl, a subsidiary of CSL Denmark ApS, is a sales and marketing company for plasma products manufactured by ZLB Bioplasma AG. ZLB Bioplasma Italy srl, a subsidiary of CSL Denmark ApS, is a sales and marketing company for plasma products manufactured by ZLB Bioplasma AG. CSL UK Holdings Limited, a subsidiary of CSL Denmark ApS, is the holding company for the United Kingdom operations of the CSL Group. JRH Biosciences Limited, based in Andover in the United Kingdom, is a subsidiary of CSL UK Holdings Limited and is the European sales and marketing arm of JRH Biosciences Inc. ZLB Bioplasma UK Limited, a subsidiary of CSL UK Holdings Limited, is a sales and marketing company for plasma products manufactured by ZLB Bioplasma AG. ZLB GmbH, a German subsidiary of ZLB Bioplasma AG, is a sales and marketing company for plasma products manufactured by ZLB Bioplasma AG. ZLB Bioplasma AG, based at Bern in Switzerland, is one of the manufacturers of plasma products in the world with major markets in the USA and Europe. Major plasma products marketed by zlb bioplasma are Carimune NF, Carimune, Redimune, Sandoglobulin, Panglobulin, Rhophylac and Albumin. CSL Bioplasma is one of the manufacturers of plasma products in the Southern Hemispher

Page 12Next Page
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CSL:AU A$91.85 AUD +0.15

CSL Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Astellas Pharma Inc ¥1,950 JPY -27.50
Baxter International Inc $68.02 USD -0.12
Green Cross Corp/South Korea 176,000 KRW +5,000
Grifols SA €39.30 EUR +0.05
Shire PLC 5,365 GBp +55.00
View Industry Companies
 

Industry Analysis

CSL

Industry Average

Valuation CSL Industry Range
Price/Earnings 25.5x
Price/Sales 6.2x
Price/Book 11.4x
Price/Cash Flow 25.0x
TEV/Sales 5.5x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CSL LTD, please visit www.csl.com.au. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.